Problem statement: Answer the multiple choice question.
Query: Which drug exhibits a -1.975% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a) CCC(COC(C)=O)Nc1nc2c([nH]1)c(=O)n(C)c(=O)n2C
b) O=C(NCCCNC(=O)c1cnccn1)c1ccc(Cl)cc1
c) c1ccc(-c2ccc3c(c2)NCCN3)cc1
Answer: b. O=C(NCCCNC(=O)c1cnccn1)c1ccc(Cl)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(NCCCNC(=O)c1cnccn1)c1ccc(Cl)cc1
O=C(NCCCNC(=O)c1cnccn1)c1ccc(Cl)cc1
N-[3-[(4-chlorobenzoyl)amino]propyl]pyrazine-2-carboxamide